APA

Alhamlan F. S., Al-Ahdal M. N., Khalaf N. Z., Abdo A. A., Sanai F. M., Al-Ashgar H. I., Elhefnawi M., Zaid A. & Al-Qahtani A. A. (20140725). Hepatitis C virus genotype 1: how genetic variability of the core protein affects the response to pegylated-interferon and ribavirin therapy. : Journal of medical virology.

Chicago

Alhamlan F S, Al-Ahdal M N, Khalaf N Z, Abdo A A, Sanai F M, Al-Ashgar H I, Elhefnawi M, Zaid A and Al-Qahtani A A. 20140725. Hepatitis C virus genotype 1: how genetic variability of the core protein affects the response to pegylated-interferon and ribavirin therapy. : Journal of medical virology.

Harvard

Alhamlan F. S., Al-Ahdal M. N., Khalaf N. Z., Abdo A. A., Sanai F. M., Al-Ashgar H. I., Elhefnawi M., Zaid A. and Al-Qahtani A. A. (20140725). Hepatitis C virus genotype 1: how genetic variability of the core protein affects the response to pegylated-interferon and ribavirin therapy. : Journal of medical virology.

MLA

Alhamlan F S, Al-Ahdal M N, Khalaf N Z, Abdo A A, Sanai F M, Al-Ashgar H I, Elhefnawi M, Zaid A and Al-Qahtani A A. Hepatitis C virus genotype 1: how genetic variability of the core protein affects the response to pegylated-interferon and ribavirin therapy. : Journal of medical virology. 20140725.